U.S. Company Emergent BioSolutions Launches Singapore Operations

(BUSINESS WIRE)--Emergent BioSolutions launches its Singapore operations. With core competencies in product development, manufacturing, and commercialization, Emergent also recently announced formation of EPIC Bio, a Singapore-based joint venture that will focus on developing much-needed pandemic influenza vaccines and therapeutics. The joint venture will bring important technology, highly specialized skills, and economic resources into Singapore.

Back to news